by Marcene Robinson, University at Buffalo Credit: Unsplash/CC0 Public Domain Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study. The research, which sought to evaluate the difference in weight loss caused by the antidiabetic medications—both of which work to control blood sugar...
THE OBESITY SOCIETY SILVER SPRING, Md.– Although Americans spend billions on them, published research shows a lack of strong evidence that dietary supplements and alternative therapies help adults lose weight, according to a new study published in Obesity, the flagship journal of The Obesity Society (TOS). There are hundreds of weight-loss supplements like green tea extract, chitosan, guar...
Over recent years, diets that see people fast on a few days each week have increased in popularity, reinforced by images of people’s miraculous weight transformations and backed by celebrity endorsements. Image credit: zuzyusa via Pixabay (Free Pixabay licence) However, evidence to date about the effectiveness of fasting compared with more traditional diets which aim to reduce...
Becky McCall May 19, 2021 Combining an investigational agent, cagrilintide (Novo Nordisk), with semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, leads to greater weight loss than semaglutide alone in people with a body mass index (BMI) over 27 kg/m2, and the combination was well-tolerated, shows a phase 1 study. The research was presented at the online ECO 2021 meeting by Lone...
EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY The first global review of complementary medicines (herbal and dietary supplements) for weight loss in 16 years–combining 121 randomised placebo-controlled trials including nearly 10,000 adults–suggests that their use cannot be justified based on the current evidence. The findings of two studies, being presented at The European Congress on...
UNIVERSITY OF TSUKUBA IMAGE: Researchers at the University of Tsukuba have shown that an exercise regimen reduces liver steatosis and stiffness in patients with non-alcoholic fatty liver disease. These gains in hepatic health are mediated through modification of inter-organ cross-talk, circulatory organokine alterations and reductions in inflammation and oxidative stress. Because these benefits are unrelated...
THE OBESITY SOCIETY SILVER SPRING, Md.–A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes. “These exciting results suggest that there may be a...
by University of Exeter Providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing type 2 diabetes, according the results of the Norfolk Diabetes Prevention Study (NDPS) the largest diabetes prevention research study in the world in the last 30 years. The...
by Kristen Bole, University of California, San Francisco The currently popular diet of intermittent fasting that restricts eating to eight hours per day, separated by 16 hours of fasting, is not effective on its own as a means of either losing weight or for improving key metabolic health markers, according to a new study led by researchers at...
CLEVELAND CLINIC CLEVELAND: A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits...
